Recommended use of aspirin and other antiplatelet medications among adults--National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005-2008
- PMID: 22695458
Recommended use of aspirin and other antiplatelet medications among adults--National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005-2008
Abstract
Cardiovascular disease (CVD) is the most highly prevalent disease in the United States and remains the leading cause of death among adults aged ≥18 years despite advancements in treatment and prevention in recent decades. Each year, approximately 800,000 persons die from CVD, which includes coronary heart disease (CHD); the majority of those persons who die from CVD had underlying atherosclerosis. Approximately 7.9 million U.S. adults have a history of heart attack, approximately 7 million U.S. adults have a history of stroke, and, approximately 16 million U.S. adults have received a diagnosis of CHD. CVD and CHD cause a substantial economic burden in the United States. In 2010, the estimated annual cost (direct and indirect) of CVD in the United States was approximately $450 billion, including $109 billion for CHD and $54 billion for stroke alone.
Similar articles
-
Control of hypertension among adults--National Health and Nutrition Examination Survey, United States, 2005-2008.MMWR Suppl. 2012 Jun 15;61(2):19-25. MMWR Suppl. 2012. PMID: 22695459
-
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.MMWR Suppl. 2014 Oct 31;63(4):3-27. MMWR Suppl. 2014. PMID: 25356673
-
Screening for lipid disorders among adults--National Health and Nutrition Examination Survey, United States, 2005-2008.MMWR Suppl. 2012 Jun 15;61(2):26-31. MMWR Suppl. 2012. PMID: 22695460
-
Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.Am J Med. 2004 Oct 1;117(7):459-68. doi: 10.1016/j.amjmed.2004.04.017. Am J Med. 2004. PMID: 15464702 Review.
-
Update on aspirin in the treatment and prevention of cardiovascular disease.Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Am J Manag Care. 2002. PMID: 12512736 Review.
Cited by
-
Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy.Mol Biol Rep. 2016 Jun;43(6):473-84. doi: 10.1007/s11033-016-3983-1. Epub 2016 Apr 12. Mol Biol Rep. 2016. PMID: 27072373 Review.
-
Aspirin Use for the Primary Prevention of Myocardial Infarction Among Men in North Carolina, 2013.Prev Chronic Dis. 2015 Nov 19;12:E202. doi: 10.5888/pcd12.150342. Prev Chronic Dis. 2015. PMID: 26583574 Free PMC article.
-
Preventive Aspirin and Other Antiplatelet Medication Use Among U.S. Adults Aged ≥ 40 Years: Data from the National Health and Nutrition Examination Survey, 2011-2012.Public Health Rep. 2015 Nov-Dec;130(6):643-54. doi: 10.1177/003335491513000614. Public Health Rep. 2015. PMID: 26556936 Free PMC article.
-
Increasing Receipt of Women's Preventive Services.J Womens Health (Larchmt). 2015 Nov;24(11):875-81. doi: 10.1089/jwh.2015.5552. Epub 2015 Oct 8. J Womens Health (Larchmt). 2015. PMID: 26447836 Free PMC article.
-
Use of low-dose aspirin as secondary prevention of atherosclerotic cardiovascular disease in US adults (from the National Health Interview Survey, 2012).Am J Cardiol. 2015 Apr 1;115(7):895-900. doi: 10.1016/j.amjcard.2015.01.014. Epub 2015 Jan 14. Am J Cardiol. 2015. PMID: 25670639 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical